SGO guidance document for clinical trial designs in ovarian cancer: a changing paradigm.

导出 OA

翻译打印收藏纠错

作者： Thomas J,Herzog ^[1] ; Ronald D,Alvarez ^[2] ; Angeles,Secord ^[3] ; Barbara A,Goff ^[4] ; Robert S,Mannel ^[5] ; Bradley J,Monk ^[6] ; Robert L,Coleman ^[7]

作者单位： University of Cincinnati, Cincinnati, OH, USA. ^[1] University of Alabama at Birmingham, Birmingham, AL, USA. ^[2] Duke Cancer Institute, Durham, NC, USA. ^[3] University of Washington, Seattle, WA, USA. ^[4] University of Oklahoma, Oklahoma City, OK, USA. ^[5] University of Arizona Cancer Center, Phoenix, AZ, USA. ^[6] The University of Texas, MD Anderson Cancer Center, Houston, TX, USA. Electronic address: rcoleman@mdanderson.org. ^[7]

关键词 Clinical trial endpoints Ovarian cancer Overall survival Patient reported outcomes Progression free survival

主题词临床试验(主题)(Clinical Trials as Topic);女(雌)性(Female);人类(Humans);卵巢肿瘤(Ovarian Neoplasms);诊疗准则(主题)(Practice Guidelines as Topic);研究设计(Research Design);治疗结果(Treatment Outcome)

DOI 10.1016/j.ygyno.2014.08.004

PMID 25124162

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交